Related by context. All words. (Click for frequent words.) 81 sorafenib Nexavar R 79 evaluating tivozanib 77 FOLFOX6 chemotherapy regimen 75 HER2 positive metastatic breast 75 gemcitabine chemotherapy 75 docetaxel chemotherapy 74 pertuzumab 74 galiximab 74 relapsed MM 74 erlotinib Tarceva ® 74 sorafenib Nexavar 74 pegylated liposomal doxorubicin 74 carboplatin paclitaxel 73 5 FU leucovorin 73 Bayer HealthCare Onyx Pharmaceuticals 73 Vidaza ® 73 trastuzumab Herceptin R 73 bortezomib Velcade R 73 sunitinib malate 73 dacarbazine 73 dacarbazine DTIC 72 pegylated interferon alfa 2a 72 daunorubicin 72 sorafenib tablets 72 plus dexamethasone 72 Imprime PGG 72 gemcitabine Gemzar 72 gemcitabine cisplatin 72 irinotecan doxorubicin oxaliplatin paclitaxel 72 bevacizumab Avastin ® 72 docetaxel Taxotere R 72 paclitaxel Taxol ® 72 FOLFIRI 72 bendamustine 72 evaluating Xcytrin 71 dasatinib Sprycel 71 HGS# 71 gemcitabine carboplatin 71 idarubicin 71 5 fluorouracil leucovorin 71 temsirolimus 71 capecitabine Xeloda R 71 mapatumumab 71 TTF Therapy 71 standard chemotherapy regimens 71 CYT# potent vascular disrupting 71 Gemzar ® 71 chlorambucil 71 standard chemotherapy regimen 71 oral chemotherapeutic agent 71 infusional 5-FU/LV 71 refractory chronic lymphocytic 71 cisplatin gemcitabine 70 oral levofloxacin 70 dasatinib Sprycel ® 70 alvespimycin 70 chemotherapy FOLFOX 70 radiation chemoradiation 70 metastatic renal cell carcinoma 70 Xeloda ® 70 Doxil ® 70 refractory AML 70 HGS ETR1 70 relapsed refractory multiple myeloma 70 relapsed multiple myeloma 70 CHOP chemotherapy 70 capecitabine Xeloda 70 telaprevir dosed 70 Omacetaxine 69 docetaxel Taxotere 69 regorafenib 69 temozolomide TMZ 69 IMC A# 69 Panzem NCD 69 lenalidomide Revlimid R 69 evaluating T DM1 69 metaglidasen 69 irinotecan chemotherapy 69 cytarabine daunorubicin 69 thalidomide Thalomid 69 alfa 2a 69 prednisone CHOP 69 Folfox 69 Aflibercept 69 relapsed refractory AML 69 Panzem R NCD 69 Cloretazine 69 paclitaxel chemotherapy 69 YONDELIS 69 evaluating picoplatin 69 bortezomib Velcade 69 low dose cytarabine 69 sorafenib 69 melphalan prednisone 69 FUSILEV enhances 69 metastatic HRPC 69 ganetespib 69 FOLFOX4 69 pegylated interferon alpha 69 estramustine 69 nilotinib Tasigna ® 69 EndoTAGTM 1 69 R sorafenib tablets 69 plus prednisone prednisolone 69 interferon alfa 69 docetaxel Taxotere ® 69 Elotuzumab 69 prostate cancer HRPC 69 axitinib 69 Fludara 69 novel tubulin binding 69 Camptosar ® 69 infliximab monotherapy 69 Pemetrexed 69 DOXIL 69 liposomal formulation 69 temsirolimus Torisel ® 69 oxaliplatin Eloxatin 69 cyclophosphamide doxorubicin vincristine 69 plus gemcitabine 69 Fludara ® 69 HGS ETR2 68 MGd 68 liposomal doxorubicin 68 pomalidomide 68 heavily pretreated 68 interferon alfa 2a 68 PSMA ADC 68 trabectedin 68 5-FU/LV 68 FOLFOX6 68 blinded randomized placebo controlled 68 refractory NSCLC 68 cyclophosphamide chemotherapy 68 ceftazidime 68 Pegasys ® 68 pancreatic adenocarcinoma 68 aflibercept VEGF Trap 68 dexamethasone Decadron 68 cediranib 68 lenalidomide dexamethasone 68 elotuzumab 68 Annamycin 68 MAGE A3 ASCI 68 Alocrest 68 xenograft models 68 EOquin TM phase 68 gemcitabine 68 receptor tyrosine kinase inhibitor 68 gemcitabine Gemzar ® 68 etoposide 68 mycophenolate mofetil 68 Amrubicin 68 primary hypercholesterolemia 68 epirubicin cyclophosphamide 68 gefitinib Iressa 68 Pertuzumab 68 metastatic hormone refractory 68 plus dacarbazine 68 demonstrated antitumor activity 68 relapsed myeloma 68 dose cytarabine 68 azacitidine 68 oblimersen 68 unique alkylating agent 68 metformin sulfonylurea 68 Voreloxin 68 Peg IFN 68 bevacizumab Avastin R 67 cetuximab Erbitux R 67 BRAF inhibitor 67 Velcade bortezomib 67 Rituxan rituximab 67 Platinol ® cisplatin 67 IMiDs ® 67 imatinib Gleevec ® 67 xanthine oxidase inhibitor 67 BRIM2 67 vinorelbine 67 BAY #-# 67 nab paclitaxel 67 Phase Ib II 67 mTOR inhibitor 67 leukemia AML 67 leukemia CLL 67 ritonavir boosted 67 Bortezomib 67 KRAS wild 67 Nexavar ® 67 sunitinib Sutent ® 67 Pegasys peginterferon alfa 2a 67 sulfonylurea glimepiride 67 enzastaurin 67 paclitaxel carboplatin 67 refractory metastatic colorectal cancer 67 pegylated interferons 67 PI3K/Akt pathway inhibitor 67 cyclophosphamide methotrexate 67 HuLuc# 67 potent triglyceride lowering 67 Doxil 67 refractory multiple myeloma 67 adriamycin 67 doxorubicin cyclophosphamide 67 azacytidine 67 Ceplene/IL-2 67 virus HCV protease inhibitor 67 mitomycin 67 nonsquamous 67 CANCIDAS 67 AKT inhibitor 67 decitabine 67 cisplatin chemotherapy 67 docetaxel prednisone 67 indolent NHL 67 fluoropyrimidine 67 unresectable stage 67 Cloretazine R VNP#M 67 Seliciclib 67 lapatinib Tykerb 67 visilizumab 67 ELOXATIN 67 radiation sensitizer 67 imatinib Gleevec 67 entinostat 67 talabostat 67 erlotinib Tarceva R 67 Xanafide 67 interferon alfa 2b 67 evaluating satraplatin 67 platinum refractory 67 AEGR 67 metastatic GIST 67 potentially hepatotoxic 67 concurrent chemoradiation 67 LymphoStat B belimumab 67 HGS ETR1 mapatumumab 67 paclitaxel Taxol R 67 neratinib 67 vorinostat 67 boosted protease inhibitor 67 cytokine refractory 67 AEG# 67 rosuvastatin #mg 67 bevacizumab Avastin 67 Aplidin 66 sargramostim 66 alkylating agent 66 EGFr expressing metastatic colorectal 66 oral antidiabetic 66 anthracycline taxane 66 chemotherapeutic drug 66 Imprime PGG ® 66 cytotoxic chemotherapy 66 Skinvisible receives 66 Deforolimus 66 NXL# 66 Peginterferon 66 intra arterial chemotherapy 66 recurrent glioblastoma multiforme 66 vinca alkaloid 66 pharmacologically active isomer 66 tenofovir emtricitabine 66 viral kinetics 66 KRAS mutations occur 66 oral deforolimus 66 relapsed ovarian cancer 66 pegylated interferon peg IFN 66 Copegus ribavirin 66 NS5B polymerase 66 refractory indolent non 66 Herceptin trastuzumab 66 pegylated interferon alfa 66 Fludarabine 66 cilengitide 66 anti leukemic 66 paclitaxel poliglumex 66 antimetabolite 66 farletuzumab 66 refractory metastatic 66 teriflunomide 66 q8h 66 VEGFR2 inhibitor 66 alpha 2b 66 SCH # 66 dose escalation Phase 66 mRCC 66 Talabostat 66 ZACTIMA 66 GW# [003] 66 ribavirin RBV 66 iniparib 66 CA4P 66 temsirolimus Torisel 66 TORISEL 66 erlotinib 66 metastatic castration resistant 66 FluCAM 66 lenalidomide Revlimid ® 66 advanced hepatocellular carcinoma 66 ® lenalidomide 66 advanced metastatic renal 66 FOLFOX 66 plus prednisone 66 ACTEMRA TM 66 adecatumumab 66 recurrent metastatic ovarian cancer 66 aflibercept 66 refractory Ph + 66 temozolomide 66 follicular NHL 66 evaluating carfilzomib 66 CIMZIA ™ 66 metastatic pancreatic 66 ENMD # 66 Cetrorelix pamoate 66 pegylated interferon alpha 2a 66 topotecan 66 phase Ib 65 active comparator 65 sunitinib 65 doxorubicin HCl liposome injection 65 tumor xenograft models 65 radiochemotherapy 65 squamous histology 65 recurrent NSCLC 65 Degarelix 65 acute leukemias 65 Lenalidomide 65 hormone refractory metastatic prostate 65 Trastuzumab 65 Tipranavir 65 Tarceva TM 65 gp# vaccine 65 fludarabine 65 ZOLINZA 65 orally administered inhibitor 65 COPEGUS ribavirin 65 5FU 65 Cloretazine ® 65 hydroxymethyl coenzyme 65 ixabepilone 65 AVOREN 65 cabazitaxel 65 chemotherapy gemcitabine 65 cytarabine 65 ELACYT 65 CLORETAZINE TM VNP#M 65 acyclovir Lauriad R 65 abacavir lamivudine 65 metastatic colorectal carcinoma 65 paclitaxel Taxol 65 eribulin mesylate 65 azilsartan medoxomil 65 Combination therapy 65 postoperative chemotherapy 65 docetaxel 65 PegIFN RBV 65 bleomycin 65 Naive Patients 65 proteasome inhibitor bortezomib 65 Taxotere ® 65 anti EGFR antibody 65 dose dexamethasone 65 Navelbine 65 peginterferon alfa 2b 65 ThermoDox R 65 folinic acid FA 65 protease inhibitor PI 65 deforolimus 65 Dapagliflozin 65 heavily pretreated patients 65 ErbB2 positive 65 imatinib resistant 65 Xelox 65 Gleevec resistant 65 cetuximab Erbitux ® 65 selective orally bioavailable 65 PD LID 65 treatment naïve genotype 65 cortisol synthesis 65 TMC# r 65 PEGINTRON TM 65 ritonavir boosted atazanavir 65 EGFR expressing mCRC 65 ABVD 65 Tamibarotene 65 antiangiogenic therapy 65 HCV NS5B polymerase 65 Bevacizumab 65 OMP #M# 65 ara C 65 Platinol ® 65 papillary renal cell carcinoma 65 chemotherapy docetaxel 65 sapacitabine 65 Erlotinib 65 TO AVOID PREGNANCY WHILE 65 EOquin TM 65 MYDICAR ® 65 alpha folate receptor 65 nucleoside analog 65 ongoing Phase 1b 65 cisplatin carboplatin 65 PREZISTA rtv 65 pancreatic NET 65 Leukine ® 65 metastatic malignant 65 oral rivaroxaban 65 Irinotecan 65 CTA# Injection 65 sapacitabine CYC# 65 tanespimycin 65 metastatic androgen independent 65 fluorouracil 65 Amplimexon 65 MabCampath 65 chemotherapeutic regimens 65 uric acid lowering 65 INCB# [001] 65 Epothilone D 65 mixed hyperlipidemia 65 Tyrima 65 ® bortezomib 65 relapsed SCLC 65 amrubicin 65 ChronVac C R 65 Teriflunomide 65 Jevtana 65 CTAP# Capsules 65 Gemzar gemcitabine 65 valsartan amlodipine 65 Ibritumomab Tiuxetan 65 Targretin capsules 64 maximally tolerated dose 64 metformin sulfonylureas 64 TREANDA 64 Gemcitabine 64 darunavir ritonavir 64 double blinded placebo 64 cisplatin vinorelbine 64 stage IIIb IV 64 chemotherapy cisplatin 64 rhIGFBP 3 64 superficial bladder cancer 64 HCV SPRINT 64 Peginterferon Alfa 2a 64 LHRH antagonists 64 Taxotere R 64 Randomized Phase 64 Rigel R# 64 Prescription acetaminophen 64 OncoVEX GM CSF 64 FOLFOX chemotherapy 64 CIMZIA TM 64 tigecycline 64 mitoxantrone plus 64 forodesine 64 IFN α 64 PREZISTA r 64 refractory cutaneous T 64 Zolinza 64 neoadjuvant treatment 64 dose melphalan 64 Flu Cy 64 bortezomib 64 CML CP 64 double blinded randomized 64 neoadjuvant chemotherapy 64 mCRC patients 64 Taxotere docetaxel 64 novel VDA molecule 64 APTIVUS 64 XELOX 64 carboplatin chemotherapy 64 Chemophase 64 oral prodrug 64 Sapacitabine 64 Temsirolimus 64 AVASTIN 64 carboplatin 64 evaluating bavituximab 64 oral allopurinol 64 irbesartan 64 glioblastoma multiforme GBM 64 Triapine 64 OXi# 64 Blinatumomab 64 Albuferon TM 64 imetelstat 64 pegylated interferon alfa 2b 64 dextromethorphan quinidine 64 Taxotere chemotherapy 64 microbiological eradication 64 anti angiogenic agents 64 assessing T DM1 64 nucleoside reverse transcriptase inhibitor 64 Hormone Refractory Prostate Cancer 64 receptor inhibitor 64 PegIFN 64 Oral NKTR 64 micafungin 64 Ceflatonin R 64 Pegasys R 64 K ras mutations 64 oral clodronate 64 fenofibric acid 64 8mg/kg 64 stage IIIB IV 64 nonsmall cell lung cancer 64 relapsing multiple sclerosis 64 Vidaza R 64 Combo Stent 64 IMiDs 64 Ophena TM 64 2 methoxyestradiol 64 prednisone prednisolone 64 hA# 64 nitazoxanide 64 tocilizumab 64 pemetrexed 64 intravenous belinostat 64 Allovectin 7 ® 64 daily Infergen 64 IMPDH inhibitor 64 taxane chemotherapy 64 amphotericin B 64 gastrin analogue TT 64 PKC# 64 systemic ALCL 64 TACE 64 recombinant PSMA vaccine 64 Zemplar Capsules 64 recurrent glioblastoma 64 idraparinux 64 rituximab Rituxan 64 Nexavar sorafenib 64 Bezielle 64 PRT# 64 Revlimid lenalidomide 64 metastatic colorectal 64 remission induction 64 serologically active systemic lupus 64 panobinostat 64 PEG IFN 64 VNP#M 64 hematological malignancy 64 doripenem 64 RG# [001] 64 seliciclib 64 alkylating 64 oral picoplatin 64 Lenocta 64 IMA# 64 potent topoisomerase II 64 signal transduction inhibitor 64 oral ridaforolimus 64 biliary tract cancer 64 chemotherapeutic regimen 64 vidofludimus 64 proteasome inhibitor 64 Aplidin R 64 Peginterferon alfa 2b 64 APTIVUS r 64 placebo dexamethasone 64 sodium glucose cotransporter 64 Ixempra 64 ospemifene 64 gefitinib 64 YONDELIS R 64 plus DOXIL 64 investigational protease inhibitor 64 inflammatory PDE 64 COPEGUS R 64 trastuzumab emtansine T DM1 64 gemtuzumab ozogamicin 64 huN# DM1 64 fluticasone salmeterol 64 metastatic CRC 64 5 Fluorouracil 64 FOLFOX regimen 64 Trastuzumab DM1 64 VELCADE melphalan 64 Trabectedin 64 AAG geldanamycin analog 64 Budesonide foam crofelemer 64 monoclonal antibody IgG1 Mab 64 metastatic castrate resistant 64 chemotherapeutic agents carboplatin 64 CBLC# 63 Quinamed 63 XL# anticancer compounds 63 Soft Tissue Sarcoma 63 Nilotinib 63 sulphonylurea 63 Hycamtin ® 63 prednisone prednisolone plus 63 refractory CLL 63 relapsed acute myelogenous 63 intravenous RSD# 63 3TC lamivudine Epivir 63 CoFactor 63 PROSTVAC VF 63 metastatic kidney 63 locoregional 63 lintuzumab 63 Multiple Myeloma MM 63 Pegylated Interferon 63 Fulvestrant 63 Targretin 63 INSPIRE Trial Phase III 63 Neulasta R 63 trastuzumab Herceptin ® 63 certolizumab 63 phase IIb clinical 63 stage IIIB 63 peginterferon alpha 2a 63 DMARDs 63 Azacitidine 63 immunomodulator 63 Meets Primary Endpoint 63 unresectable Stage III 63 overlapping toxicities 63 mcg albinterferon alfa 2b 63 efavirenz EFV 63 systemic anaplastic large 63 TKI therapy 63 somatostatin analog 63 PHX# 63 relapsed refractory 63 Clolar ® 63 acute promyelocytic leukemia APL 63 compound INCB# 63 tyrosine kinase inhibitor 63 echinocandin 63 FEMALES SHOULD BE ADVISED 63 Pegylated Liposomal Doxorubicin 63 Capecitabine 63 NovoTTF 63 monotherapy 63 alpha 2a 63 ascending dose 63 HuMax EGFr 63 BENICAR HCT 63 ER CHOP 63 advanced nonsquamous NSCLC 63 bexarotene 63 TEMODAL 63 glufosfamide 63 fluvastatin 63 Phase Ib 63 APTIVUS R 63 basal cell carcinoma BCC 63 eribulin 63 BR.# 63 miconazole Lauriad ® 63 cell lymphoma CTCL 63 vinorelbine tartrate 63 PegIntron 63 chemoradiation 63 low dose dexamethasone 63 pegylated liposomal doxorubicin PLD 63 Tekamlo 63 resistant ovarian cancer 63 pharmacokinetic PK study 63 tolerability pharmacokinetics 63 interferon gamma 1b 63 Crofelemer budesonide foam 63 FOLFIRI alone 63 Pegylated interferon 63 biologic DMARD 63 brand ciclesonide HFA 63 CINQUIL 63 pain palliation 63 MEK inhibitors 63 PEGylated Fab fragment 63 Dasatinib 63 Omnitarg 63 Doxorubicin 63 HMG CoA reductase inhibitors 63 advanced unresectable 63 Interferon alfa 63 IMiDs R 63 lipid lowering agents 63 Tarceva erlotinib 63 refractory chronic myeloid 63 Pfizer Camptosar 63 selective kinase inhibitor 63 Platinol 63 chemotherapy hormonal therapy 63 salmeterol fluticasone 63 comparator arm 63 PEG interferon 63 XmAb# 63 transaminase elevation 63 kidney urologic 63 TELCYTA 63 commercializes implantable 63 GRN#L 63 pegfilgrastim 63 peginterferon 63 telaprevir pegylated interferon 63 plus ribavirin 63 nucleoside analogs 63 AGILECT R 63 plus Copegus R 63 velafermin 63 paclitaxel cisplatin 63 clinically evaluable 63 evaluating mipomersen 63 investigational HCV polymerase 63 oral proteasome inhibitor 63 lumiliximab 63 Pivotal Phase 63 evaluating Prochymal 63 cinacalcet 63 posaconazole 63 protein kinase inhibitor 63 lipid lowering therapies 63 Phase 1b trial 63 lenalidomide Revlimid 63 interferon alpha IFN alpha 63 Hycamtin 63 Panzem R 63 chemotherapy regimens 63 GMX# 63 cancer mCRC 63 taxane therapy 63 peg IFN 63 chronic lymphocytic leukemia CLL 63 neurologic progression 63 systemic antifungal 63 Onrigin 63 Temodar ® 63 metastatic ocular 63 IMiDs ® compound 63 goserelin 63 Kahalalide F 63 Avastin Tarceva 63 infusional 63 platelet inhibitor 63 novel nucleoside analog 63 mg RDEA# 63 KRN# 63 mitoxantrone 63 refractory ovarian cancer 63 Melphalan 63 piperacillin tazobactam 63 intravesical infusion therapy 63 Cetuximab Erbitux 63 ADP receptor antagonist 63 Alkeran 63 thymalfasin 63 5 fluorouracil 63 Darusentan 63 pharmacodynamic properties 63 metastatic renal cell 63 TMC# C# 63 tubulin inhibitor 63 eplerenone 63 dose dose escalation 63 locoregional recurrence 63 Aptivus ® 63 zalutumumab 63 aspirin clopidogrel 63 Taxol ® 63 Phase 1b 63 imipenem 63 peginterferon alfa 2a 63 gastrointestinal stromal tumor GIST 63 taxane refractory 63 bosutinib 63 pharmacodynamic PD 63 chemoradiotherapy 63 phase IIb study 63 palifosfamide 63 non resectable 63 Aliskiren 63 antiangiogenic agent 63 4mg/kg 63 SCCHN 63 EGFR tyrosine kinase inhibitor 63 Procoralan 63 azathioprine 63 trans retinoic acid 63 folinic acid 63 High Dose quadruples 63 tegafur 63 patients oral indibulin 63 exemestane Aromasin 63 alpha interferons 63 GRN# 63 multitargeted 63 histologies 63 Campath alemtuzumab 63 SPRYCEL ® 63 IGF 1R inhibitor 63 immunotherapeutic agent 63 cyclophosphamide FC 63 colorectal liver metastases 63 Virulizin ® 63 Elitek 63 locoregional disease 62 TNF Tumor Necrosis Factor 62 BCR ABL inhibitor 62 fallopian tube carcinoma 62 hypoxia selective 62 Glufosfamide 62 Xeloda capecitabine 62 Vidaza azacitidine 62 induced tumor regression 62 calcineurin inhibitors 62 DFMO 62 gadobutrol 62 Cytoxan 62 Linaclotide 62 metastatic RCC 62 Vandetanib 62 oral anti arrhythmic 62 bortezomib Velcade ® 62 nucleotide analog 62 Evoltra ® 62 Myocet 62 TRAIL R1 62 PrevOnco ™ 62 myelofibrosis polycythemia vera 62 everolimus tablets 62 erlotinib Tarceva 62 Sanofi Aventis Taxotere 62 DOXIL ® 62 corticosteroid dexamethasone 62 vandetanib 62 nucleotide analogue 62 evaluating Actimmune 62 inhaled corticosteroid ICS 62 Myelodysplastic Syndrome MDS 62 Phase 1b clinical trials 62 octreotide LAR 62 inhaled TPI ASM8 62 dependent kinase inhibitor 62 desvenlafaxine succinate 62 LHRH receptor positive 62 chemotherapeutic agent 62 Cisplatin 62 abatacept Orencia 62 investigational integrase inhibitor 62 Paraplatin ® 62 Epratuzumab 62 Abiraterone acetate 62 DEB# 62 oral Hycamtin 62 Pharmacokinetic parameters 62 ACE Inhibitor 62 carcinoma mCRC 62 nilotinib Tasigna 62 CIMZIA TM certolizumab pegol 62 antidiabetic 62 TRISENOX 62 recurrent metastatic 62 mCRC 62 previously untreated follicular 62 treatment naive genotype 62 romidepsin 62 neoadjuvant 62 zoledronate 62 BMS # 62 Mg Uk 62 nonrandomized 62 RG# ITMN 62 ocular formulation 62 HBeAg positive 62 celgosivir 62 davunetide intranasal AL 62 antitumor effect 62 D aspartate NMDA receptor 62 IAP inhibitor 62 PSN# [001] 62 lesinurad 62 PREZISTA ritonavir 62 Carfilzomib 62 taxotere 62 R#/MEM # 62 taxane 62 refractory CTCL 62 vincristine doxorubicin 62 obatoclax 62 Mg Usa 62 aliskiren amlodipine 62 non metastatic resectable 62 mg administered orally 62 DU #b 62 metastatic relapsed 62 advanced NSCLC 62 pathophysiological effects 62 EGFR inhibitors 62 letrozole Femara 62 somatostatin analogue 62 Genasense ® 62 3mg/kg 62 EGFR TKI 62 opioid naive 62 liposomal amphotericin B 62 alefacept 62 trandolapril 62 developing Bicifadine serotonin 62 relapsed CLL 62 cariprazine 62 raltegravir 62 steroid dexamethasone 62 Anthracycline 62 IV bolus formulation 62 CD4 monoclonal antibody 62 methotrexate MTX 62 statin simvastatin 62 Triapine R 62 dexpramipexole 62 insulin sensitizing 62 bezafibrate 62 Phase #b/#a clinical 62 IIIa inhibitor 62 Navelbine ® 62 fibrate drugs 62 preoperative chemotherapy 62 COU AA 62 PSN# [002] 62 follicular lymphoma FL 62 clinical trials Archexin 62 oral antiviral 62 essential thrombocythemia ET 62 dasatinib 62 ATACAND 62 fosbretabulin 62 capecitabine 62 progressive metastatic prostate 62 plus COPEGUS 62 μg dose 62 Cyclophosphamide 62 autoantibody positive 62 irinotecan containing 62 Taxol paclitaxel 62 vinca alkaloids 62 cetuximab 62 chemoradiation therapy 62 Traficet EN 62 doxorubicin docetaxel 62 interferon IFN 62 cutaneous T 62 ThermoDox 62 CYPHER Stent 62 Sym# 62 humanised monoclonal antibody 62 investigational monoclonal antibody 62 CVP chemotherapy 62 randomized Phase III 62 small molecule Hedgehog 62 dacarbazine chemotherapy 62 nicardipine 62 cisplatin 62 Mitoxantrone 62 imatinib therapy 62 denileukin diftitox 62 depsipeptide 62 DNA methyltransferase inhibitors 62 tumors GIST 62 irinotecan cisplatin 62 tumor vascular disrupting 62 evaluating adecatumumab 62 hepatocellular cancer 62 multicenter Phase III 62 dose regimens 62 cisplatin resistant 62 class mGluR5 inhibitor 62 Gastrointestinal Stromal Tumors 62 ZK EPO 62 MIRAPEX ER 62 molecularly targeted 62 Thiarabine 62 doxorubicin 62 EOquin 62 NMIBC 62 Pazopanib 62 vemurafenib 62 hematopoietic cancers 62 PrevOnco 62 IAP inhibitors 62 registrational Phase 62 thiazide diuretic 62 dacetuzumab 62 lispro 62 multicentre randomized 62 microtubule inhibitor 62 atrial fibrillation budiodarone ATI 62 ularitide 62 sarcoma melanoma 62 Sanofi Pasteur Fluzone 62 DexaSite 62 TYKERB 62 asymptomatic metastatic 62 Camptosar ® irinotecan